This prediction was later partly confirmed by the most recent reports that IDH mutations suppress STAT1 and CD8+ T cell accumulation and downregulate leukocyte chemotaxis in gliomas (Amankulor et al., 2017; Kohanbash et al., 2017). The gene discussed is IDH1; the disease is central nervous system cancer.